Genomics of Shiga toxin-producing Escherichia coli from asymptomatic carriers in Japan highlights risk-adaptive control

日本无症状携带者体内产志贺毒素大肠杆菌的基因组学研究凸显了风险适应性控制的重要性

阅读:4

Abstract

Shiga toxin-producing Escherichia coli (STEC) is detected in healthy individuals, who face work restrictions to prevent secondary transmission. To assess the virulence potential, we sequence 495 STEC isolates from healthy food handlers and social welfare workers in 2021 and compare them with 250 isolates from symptomatic patients. Nineteen serotypes (e.g., O156:H25, O174:H21, O105:H7) are significantly associated with asymptomatic carriers (SAAC), while five serotypes (O157:H7, O26:H11, O111:H8, O121:H19, O145:H28) are significantly associated with symptomatic patients (SAPA). SAPA strains frequently carry major virulence factors, including the LEE-encoded type III secretion system (100%) and Shiga toxin 2a (63.2%), which are less common in SAAC strains (38.3% and 3.7%). Among the 495 carrier isolates, 35 (7.1%) are high-risk, 178 (36.0%) moderate-risk, and 282 (57.0%) low-risk based on serotype and virulence markers. These findings suggest many strains in asymptomatic carriers have limited virulence, underscoring the need for risk-based strategies that avoid unnecessary restrictions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。